Skip to content
OpenCapital
Get started

HealthEquity HQY Payments for (Proceeds from) Derivative Instrument, Investing Activities

Payments for (Proceeds from) Derivative Instrument, Investing Activities at other companies

Voya Financial logo
Voya FinancialVOYA
——

Other financials

Income statement

See full
Revenue$354.6M+7.2%
Gross profit$256.3M+14.3%
Operating income$103.0M+23.9%
Net income$69.4M+28.8%
EPS (diluted)$0.82+34.4%

Balance sheet

See full
Cash & equivalents$265.4M-7.8%
Total debt$984.7M-11.0%
Total equity$2.0B-3.6%
Total assets$3.3B-3.2%

Cash flow

See full
Operating cash flow$97.5M+50.6%
CapEx$362.0K+321%
Free cash flow$97.2M+50.3%

Valuation

See full
Market cap$7.12B-6.7%
Enterprise value$7.84B-7.2%
P/E30.9×-31.8×
P/S5.3×-0.8×

Profitability

See full
Gross margin70.7%+5.2pp
Operating margin25.6%+9.2pp
Net margin17.3%+7.5pp
FCF margin36.5%+9.3pp

Returns & leverage

See full
Return on equity11.1%+5.3pp
Debt / equity0.5×0.0×
Current ratio3.4×-0.6×

Where this comes from

Reported directly by HealthEquity in its filing.

Tagged under the XBRL concept us-gaap:PaymentsForProceedsFromDerivativeInstrumentInvestingActivities.

The official record: HealthEquity’s 10-Q, filed May 28, 2026, on SEC EDGAR. View the filing →

Ask your AI about HealthEquity's payments for (proceeds from) derivative instrument, investing activities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is HealthEquity's payments for (proceeds from) derivative instrument, investing activities?
HealthEquity (HQY) reported payments for (proceeds from) derivative instrument, investing activities of -$2.39M in Q1 2026.
What does payments for (proceeds from) derivative instrument, investing activities mean?
This captures the net cash flows resulting from the settlement or acquisition of derivative instruments classified as investing activities. It reflects the company's strategy for managing financial risks, such as interest rate or currency fluctuations, through market instruments. Investors monitor this to gauge the effectiveness and cost of the company's risk management program.